Sign up for Table of Contents Alerts.
Email this page
Print this page
Research Paper
Proteomic analysis of cervical cancer cells treated with adenovirus-mediated MDA-7
Lili Wei, Zhongtang Wang, Tao Cui, Faping Yi, Youquan Bu, Songtao Ding, Yongping Ma and Fangzhou Song
volume 7 | issue 4
April 2008Pages: 510 - 516
Subscribe to this journal for $129/year
Ad.mda-7 inhibited growth and decreased survival in a broad array of human tumor cells, without eliciting detrimental effects in normal cells. This study demonstrates that Ad.mda-7 can effectively impede the proliferation and induce apoptosis of human cervical carcinoma cells, but the underlying mechanisms inducing cell death at protein level are unknown. Using proteome analysis, an investigation aimed at a better understanding of the antiproliferative mechanisms by Ad.mda-7 was carried out in CaSki cervical cancer cells. A total of 43 differentially expressed proteins were visualized by 2-DE and silver stain., 29 proteins of which were identified via matrix-assisted laser desorption/ionization-time of flight mass spectrometry(MALDI-TOF-MS) analysis, 15 were upregulated (eg, Tumor suppressor p53、Apoptosis regulator BAX、Adenylate kinase isoenzyme 1(AK1)、Growth arrest and DNA-damage-inducible protein GADD45 gamma (GADD45γ)) and 14 were downregulated (eg, Eukaryotic translation initiation factor 5A(eIF-5A)、Protein DJ-1、Annexin V、Transcription elongation factor B polypeptide 2 (TCEB2)、TRAF family member-associated NF-kappa-B activator (TRAF2)、c-Myc-responsive protein Rcl (RCL)). Among the identified proteins, the protein and mRNA alterations of six proteins were further confirmed by Western blot and semi-quantitative RT-PCR. Together, at both the mRNA and protein levels, p53, BAX, AK1, GADD45γ, and BCCIP were upregulated, while eIF-5A was downregulated following Ad.mda-7 treatment. Our findings may offer new insights into the antiproliferative mechanisms by Ad.mda-7 and its mode of action in cervical carcinoma cells.
Authors
Lili Wei
Department of Biochemistry and molecular biology, Chongqing University of Medical Sciences
Zhongtang Wang
Sixth Department of Radiation Oncology, Shandong Cancer Hospital; China.
Tao Cui
Department of Biochemistry and molecular biology, Chongqing University of Medical Sciences
Faping Yi
Department of Biochemistry and molecular biology, Chongqing University of Medical Sciences
Youquan Bu
Department of Biochemistry and molecular biology, Chongqing University of Medical Sciences
Songtao Ding
Department of Biochemistry and molecular biology, Chongqing University of Medical Sciences
Yongping Ma
Department of Biochemistry and molecular biology, Chongqing University of Medical Sciences
Fangzhou Song
Key Laboratory of Clinical Medical Diagnostics of Education Ministry





